News Related to Mucositis

Related coverage linked through entity extraction aliases.

Neoadjuvant Immunotherapy Shows High Response Rates in Desmoplastic Melanoma

Feb 27, 2026

Neoadjuvant pembrolizumab achieved 71% pathologic complete response in desmoplastic melanoma patients, while lower-dose ipilimumab combination therapy showed improved survival and fewer side effects in advanced melanoma treatment.

Advances in Head and Neck Cancer Treatment Focus on Reducing Radiation Toxicity

Feb 14, 2026

New research and precision radiation techniques aim to minimize debilitating side effects of head and neck cancer treatment, including oral mucositis, while maintaining tumor control and improving patient quality of life.